Home › Criticism › No measurable marker
No measurable marker for gender identity
After decades of research, there is not a single biological test that can establish or refute "gender identity." No blood value, no hormone profile, no scan, no gene. What remains is a creed—which nevertheless justifies puberty blockers, hormone therapy, and mastectomies in healthy minors.
What a marker should be
A biological marker is a measurable indicator of a biological state. For diabetes: HbA1c. For pregnancy: hCG. For sex : gametes, karyotype, gonadal anatomy. For "gender identity": nothing. No lab test, no scan, no criterion. It is impossible for a doctor to determine that someone has a "female gender identity" — he can only repeat what the patient says. That is not diagnosis; that is dictation.
What research has tried — and did not find
Brain scans (see no brain marker ), genetic studies (see no genetic marker ), hormone levels, finger length ratios, classic "transbrain" claims surrounding the Zhou-BSTc study : nothing yielded a consistent, replicable, clinically useful distinction. The Cass Review (2024) concludes starkly: "There is no reliable biomarker that predicts who will or will not benefit from medical intervention." Sweden ( SBU ), Finland ( COHERE ), the UK ( NICE ), Denmark, and Norway independently reached the same conclusion.
The epistemic consequence
Without a marker, only self-reporting remains. But self-reporting without an independent criterion immediately falls into circular reasoning : "I am trans because I feel trans, and I feel trans because I am trans." This is not a detail. It is a fundamental epistemic defect. In operational terms, we do not even know what we are talking about. The claim is unfalsifiable and is therefore, strictly speaking, a metaphysical claim , not a scientific one.
Comparison with actual diagnoses
For depression or ADHD, direct biomarkers are lacking, yet validated behavioral scales, observation criteria, and outcome measures exist. For "gender identity": only the claim itself. This difference makes the concept fundamentally unsuitable as a basis for irreversible medical interventions. In no other medical domain would such a void be accepted—here it is, because criticism is silenced and anyone who asks questions is dismissed as transphobic.
Yes, but major, recent reviews (Cass 2024, SBU 2022) conclude that after decades of research, nothing useful has been found. The pattern—searching without finding, adjusting claims without evidence—fits an ideology, not a science.
It makes it a reported experience, not a verified condition. The difference is large enough not to base a scalpel or GnRH analog on.
It certainly plays a role. Positive studies are amplified, negative ones suppressed. See publication bias and fraud in this field.
Sources
- Cass, H. (2024). Independent Review: Final Report . cass.independent-review.uk
- SBU (2022). Hormone therapy at gender dysphoria in adolescents . Swedish Agency for Health Technology Assessment.
- Hruz, P. (2020). Deficiencies in scientific evidence. Linacre Quarterly , 87(1).